Jonas from Romania

Registered at the short selling broker IQ Option, 4 minutes ago.

» Try IQ Option you too
87% of retail investor accounts lose money when trading CFDs with IQ Option.
Don't show again

AbbVie, Inc. (ABBV) shares information

Abbvie Inc


24h Change

0.42 %

ABBV

Live rate: Market closed

Stock data per Friday 1 Jul, 2022

ABBV
NEW YORK STOCK EXCHANGE INC.
153.16
153.08
153.80
0.64 (+ 0.42%)
US Market is closed

Live Stock price in graph for Abbvie Inc (ABBV)

  • Latest Volume

    4,619,958 (-36.62 %)

  • Volume prev. day

    7,289,474

  • Avg. daily volume

    6,353,961

  • Market cap

    271,781,530,765

  • P/E ratio

    22.03

  • Today high

    153.86 USD

  • Today low

    151.459 USD

  • 52 week high

    174.43 USD

  • 52 week low

    102.35 USD

  • YTD Change

    + 16.16 %

Quick links

 

Latest news about Abbvie Inc

Below you can find the most recent news posts about Abbvie Inc, primarily from US and UK based news sources.

Genmab”s Epcoritamab BLA Application a Positive for AbbVie – Morgan Stanley

Friday, 1 July 2022, 22:12:10
https://www.investing.com/news/stock-market-news/genmabs-epcoritamab-bla-application-a-positive-for-abbvie–morgan-stanley-2843303
— Investing.com


AbbVie (ABBV): Buy This Dividend King For Growing Income Stream

Friday, 1 July 2022, 10:28:11
AbbVie delivered mid-single-digit revenue growth and high-single-digit adjusted diluted EPS in Q1. See why I still believe ABBV stock is a buy.
— Seeking Alpha


Uveitis Drugs Market Trend Analysis by 2022: Growth Prospective, Regional Demand, Product End-users and Forecast to 2028 | AbbVie Inc., Alimera Sciences Inc.

Thursday, 30 June 2022, 09:06:01
The SMI released the latest competent intelligence market research report on Uveitis Drugs Market, The report aims to provide a thorough and accurate analysis of the global Uveitis Drugs market, taking into account market forecast, competitive intelligence, technical risks, innovations,
— OpenPR


Check Out What Whales Are Doing With ABBV

Wednesday, 29 June 2022, 19:04:50
Someone with a lot of money to spend has taken a bullish stance on AbbVie (NYSE: ABBV ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don”t know. But when something this big happens with ABBV, it often means somebody knows something is about to happen. So how do we know what this whale just did? Today, Benzinga ”s options scanner spotted 18 uncommon options trades for AbbVie. This isn”t normal. The overall sentiment of these big-money traders is split between 61% bullish and 38%, bearish. Out of all of the special options we … Full story available on Benzinga.com
— Benzinga


Analyzing AbbVie”s Short Interest

Wednesday, 29 June 2022, 15:03:32
AbbVie”s (NYSE: ABBV ) short percent of float has risen 27.78% since its last report. The company recently reported that it has 13.52 million shares sold short , which is 0.92% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.9 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price … Full story available on Benzinga.com
— Benzinga


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have ABBV available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.